Vinpocetine Inhibited the CpG Oligodeoxynucleotide-induced Immune Response in Plasmacytoid Dendritic Cells

References

• Bae, KR, Shim, HJ, Balu D, et al. (2014). Translocator protein 18 kDa negatively regulates inflammation in microglia. J Neuroimmune Pharmacol, 9, 424–437.
   PubMed Web of Science ®Google Scholar
• Bao M, Liu, YJ (2013). Regulation of TLR7/9 signaling in plasmacytoid dendritic cells. Protein Cell, 4, 40–52.
   PubMed Web of Science ®Google Scholar
• Beaudoin L, Diana J, Ghazarian L, et al. (2014). Plasmacytoid dendritic cells license regulatory T cells, upon iNKT-cell stimulation, to prevent autoimmune diabetes. Eur J Immunol, 44, 1454–1466.
   PubMed Web of Science ®Google Scholar
• Bereczki D, Fekete I (1999). A systematic review of vinpocetine therapy in acute ischaemic stroke. Eur J Clin Pharmacol, 55, 349–352.
   PubMed Web of Science ®Google Scholar
• Caielli S, Conforti-Andreoni C, Di Pietro C, et al. (2010). On/off TLR signaling decides proinflammatory or tolerogenic dendritic cell maturation upon CD1d-mediated interaction with invariant NKT cells. J Immunol, 185, 7317–7329.
   PubMed Web of Science ®Google Scholar
• Chen J, Tan Z, Liu H, et al. (2006). Expression of plasmacytoid dendritic cells, IRF-7, IFN-alpha mRNA in the lesions of psoriasis vulgaris. J Huazhong Univ Sci Technolog Med Sci, 26, 747–749.
   PubMedGoogle Scholar
• Diana J, Simoni Y, Furio L, et al. (2013). Crosstalk between neutrophils, B-1a cells and plasmacytoid dendritic cells initiates autoimmune diabetes. Nat Med, 19, 65–73.
   PubMed Web of Science ®Google Scholar
• Fallarino F, Asselin-Paturel C, Vacca C, et al. (2004). Murine plasmacytoid dendritic cells initiate the immunosuppressive pathway of tryptophan catabolism in response to CD200 receptor engagement. J Immunol, 173, 3748–3754.
   PubMed Web of Science ®Google Scholar
• Gottenberg, JE, Cagnard N, Lucchesi C, et al. (2006). Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjogren’s syndrome. Proc Natl Acad Sci USA, 103, 2770–2775.
   PubMed Web of Science ®Google Scholar
• Gulyas B, Halldin C, Vas A, et al. (2005). [11C]vinpocetine: a prospective peripheral benzodiazepine receptor ligand for primate PET studies. J Neurol Sci, 229–230, 219–223.
   Google Scholar
• Guzylack-Piriou L, Balmelli C, McCullough, KC, Summerfield A (2004). Type-A CpG oligonucleotides activate exclusively porcine natural interferon-producing cells to secrete interferon-α, tumour necrosis factor-α and interleukin-12. Immunology, 112, 28–37.
   PubMed Web of Science ®Google Scholar
• Honda K, Ohba Y, Yanai H, et al. (2005). Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction. Nature, 434, 1035–1040.
   PubMed Web of Science ®Google Scholar
• Issop L, Ostuni, MA, Lee S, et al. (2016). Translocator protein-mediated stabilization of mitochondrial architecture during inflammation stress in colonic cells. PLoS One, 11, e0152919.
   Web of Science ®Google Scholar
• Jeon, KI, Xu X, Aizawa T, et al. (2010). Vinpocetine inhibits NF-kappaB-dependent inflammation via an IKK-dependent but PDE-independent mechanism. Proc Natl Acad Sci USA, 107, 9795–9800.
   PubMed Web of Science ®Google Scholar
• Krieg, AM. (2002). CpG motifs in bacterial DNA and their immune effects. Annu Rev Immunol, 20, 709–760.
   PubMed Web of Science ®Google Scholar
• Lande R, Ganguly D, Facchinetti V, et al. (2011). Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA-peptide complexes in systemic lupus erythematosus. Sci Transl Med, 3, 73ra19.
   PubMed Web of Science ®Google Scholar
• Lande R, Giacomini E, Serafini B, et al. (2004). Characterization and recruitment of plasmacytoid dendritic cells in synovial fluid and tissue of patients with chronic inflammatory arthritis. J Immunol, 173, 2815–2824.
   PubMed Web of Science ®Google Scholar
• Lim, TS, Goh, JK, Mortellaro A, et al. (2012). CD80 and CD86 differentially regulate mechanical interactions of T-cells with antigen-presenting dendritic cells and B-cells. PLoS One, 7, e45185.
   PubMed Web of Science ®Google Scholar
• Livak, KJ, Schmittgen, TD. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods, 25, 402–408.
   PubMed Web of Science ®Google Scholar
• Ma, DY, Clark, EA. (2009). The role of CD40 and CD154/CD40L in dendritic cells. Semin Immunol, 21, 265–272.
   PubMed Web of Science ®Google Scholar
• Morelli, AE, Thomson, AW. (2007). Tolerogenic dendritic cells and the quest for transplant tolerance. Nat Rev Immunol, 7, 610–621.
   PubMed Web of Science ®Google Scholar
• Repalli J (2014). Translocator protein (TSPO) role in aging and Alzheimer’s disease. Curr Aging Sci, 7, 168–175.
   PubMedGoogle Scholar
• Sauer D, Rischke R, Beck T, et al. (1988). Vinpocetine prevents ischemic cell damage in rat hippocampus. Life Sci, 43, 1733–1739.
   PubMed Web of Science ®Google Scholar
• Stasiolek M, Bayas A, Kruse N, et al. (2006). Impaired maturation and altered regulatory function of plasmacytoid dendritic cells in multiple sclerosis. Brain, 129, 1293–305.
   PubMed Web of Science ®Google Scholar
• Szatmari, SZ, Whitehouse, PJ (2003). Vinpocetine for cognitive impairment and dementia. Cochrane Database Syst Rev, 1, CD003119.
   Google Scholar
• Tel J, van der Leun, AM, Figdor, CG, et al. (2012). Harnessing human plasmacytoid dendritic cells as professional APCs. Cancer Immunol Immunother, 61, 1279–1288.
   PubMed Web of Science ®Google Scholar
• Wang, YZ, Lv H, Hao, YL, et al. (2015). Suppressive oligodeoxynucleotides induced tolerogenic plasmacytoid dendritic cells and ameliorated the experimental autoimmune neuritis. Immunol Lett, 166, 13–18.
   PubMed Web of Science ®Google Scholar
• Zhao, YY, Yu, JZ, Li, QY, et al. (2011). TSPO-specific ligand vinpocetine exerts a neuroprotective effect by suppressing microglial inflammation. Neuron Glia Biol, 7, 187–197.
   PubMedGoogle Scholar